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Abstract
Background: Non-viral vectors for gene transfer are less immunogenic than viral vectors but also
less efficient. Significant effort has focused on enhancing non-viral gene transfer efficiency by
increasing nuclear import of plasmid DNA, particularly by coupling nuclear localization peptidic
sequences to plasmid DNA.
Results: We have coupled a 62-aminoacid peptide derived from hSRP1α importin beta binding
domain, called the IBB peptide to plasmid DNA by using the heterobifunctional linker N-(4-azido-
2,3,5,6 tetrafluorobenzyl)-6-maleimidyl hexanamide (TFPAM-6). When covalently coupled to
plasmid DNA, IBB peptide did not increase the efficiency of cationic lipid mediated transfection.
The IBB peptide was still able to interact with its nuclear import receptor, importin β, but non-
specifically. However, we observed a 20-fold increase in reporter gene expression with plasmid
DNA / IBB peptide complexes under conditions of inefficient transfection. In which case, IBB was
associated with plasmid DNA through self assembling ionic interaction.
Conclusions: The improvement of transfection activity was not due to an improved nuclear
import of DNA, but rather by the modification of physicochemical properties of IBB peptide /
plasmid complexes. IBB peptide increased lipoplex size and these larger complexes were more
efficient for gene transfer.
Background
Even though lipofection represents 13 % of gene therapy
clinical trials, cationic lipids remain less efficient gene
delivery vectors than viral vectors. The first obstacle in in
vivo non-viral gene transfer is the transport of plasmid
DNA from the site of injection to the targeted cell: lipo-
plexes have to circulate without being sequestered by the
reticulo-endothelial system [1] in order to reach the tar-
geted cell membrane. Lipoplexes then encounter physio-
logical barriers to their intracellular trafficking. After cell
membrane attachment, lipoplexes enter the cell cyto-
plasm either by fusion of the vector with the plasma mem-
brane or by endocytosis [2], and then inefficiently diffuse
through the cytoplasm to the nuclear envelope [3].
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Plasmid DNA carrying the therapeutic gene most fre-
quently gains access to the nucleus during mitosis, when
nuclear envelope rupture occurs [4,5]. In the case of non-
dividing cells, transfection is particularly low, presumably
because of the diffusion barrier constituted by the nuclear
envelope [5]. Consequently, much work has been done to
increase the efficiency of gene transport to the cell
nucleus. Several authors have worked on strategies mim-
icking viral genome or karyophilic protein nuclear deliv-
ery. Proteins destined to the nucleus possess at least one
nuclear localisation sequence (NLS) which allows them to
interact with a nuclear import receptor, namely importin
β q (for a review, see [6]). When complexed to importin β,
proteins are delivered to cell nuclei via nuclear pore com-
plexes. Most proteins interact with importin β via an
adapter, importin α. Importin α consists of two functional
domains, a short basic amino-terminal domain responsi-
ble for importin β binding (IBB domain) and a central
NLS-binding domain built of armadillo (arm) repeats [7–
9]. Nuclear localization sequences, and among them SV40
large T antigen NLS sequence, have been electrostatically
[10–13] or covalently [14–17] coupled to plasmid DNA
to provide an interaction with importin α. The hypothesis
was that plasmid DNA / importin α complexes would
then interact with importin β and be transported to the
nucleus by a facilitated diffusion pathway via the protein
nuclear import system. It has been reported that covalent
coupling of NLS peptides to circular plasmid DNA leads
to nuclear accumulation if more than one hundred pep-
tides per plasmid are coupled [14]. Nevertheless, such
NLS peptide-plasmid DNA chimera are not transcribed
and thus not biologically active. We have previously
described functional plasmids covalently coupled to a
limited amount of NLS sequences, which have been
shown to interact with importin α [15]. However, such
modified plasmids did not accumulate in cell nuclei [15].
Similarly, when a single NLS peptide is covalently coupled
to plasmid DNA, nuclear accumulation is not observed
[17], except in the case where plasmid DNA is highly engi-
neered. For instance, Zanta et al. linearized plasmid DNA,
capped it and coupled a single NLS peptide on one cap.
With this construction, transfection efficiency was
enhanced in several cell types [16].
These strategies require the contribution of the importin α
adapter, which could reduce the efficiency of plasmid
DNA nuclear targeting. Subramanian et al. coupled the
M9 domain of hnRNP A1 to plasmid DNA via electro-
static interactions mediated by a covalently coupled
scrambled SV40 T antigen NLS [18]. The M9 domain is
known to interact directly with transportin [19], a mem-
ber of the karyopherin β import receptor family. With this
construction, reporter gene expression was increased by
63-fold. However, a nuclear export signal (NES) is
enclosed in the M9 domain and could provide its nuclear
externalization. We hypothesized that the covalent cou-
pling of the importin α IBB domain to plasmid DNA
could mediate direct interaction between plasmid and
importin  β, without the need of an adapter. Human
importin α 2 (hSRP1α) IBB domain has been described
by Weis et al. [20]. Its structure has been shown to be
modular, with separate domains having separate func-
tions. Particularly, the 1–51 N-terminal sequence of
hSRP1α has been shown to be sufficient for importin β
interaction, with residues 21–51 being particularly impor-
tant, and residues 1–21 further enhancing binding to
importin  β [21]. No nuclear export signal has been
reported in the IBB sequence.
In the present work, our first strategy was to covalently
couple the IBB peptide hSRP1α 11–54 amino acids to
plasmid DNA. It was the first time that the IBB domain of
importin α was used as an additive in the formulation of
lipoplexes. We tested whether covalent coupling of IBB
peptide to plasmid DNA increased in vitro transfection via
enhanced nuclear import. DNA-coupled IBB was still able
to interact with importin β, also non-specifically and no
improvement of gene transfer was observed. Nevertheless,
we observed an increased reporter gene expression using
non-covalent plasmid DNA / IBB peptide self assembling
complexes. This enhancement was attributed more to
changes in the lipoplex's physico-chemical properties
than to nuclear targeting of plasmid DNA by the IBB
peptide.
Results
Cationic lipid mediated transfection of plasmid DNA-IBB 
peptide covalent chimera
The IBB peptide was covalently coupled to plasmid DNA
by photoactivation at various IBB peptide / plasmid molar
ratios. We first tried to evaluate the direct effect of IBB pep-
tide on nuclear import using transfection since our final
aim was to enhance gene transfer by transfection. When
using RPR120535 cationic lipid to mediate plasmid-IBB
peptide chimera transfection, we observed a partial dose-
dependent inhibition of reporter gene expression, which
reached 88 % at 50 IBB peptide / plasmid (mol / mol),
and 99 % at 100 IBB peptide / plasmid (mol / mol) (Fig-
ure 1). At 1 to 10 molar ratios, reporter gene expression
following transfection was neither inhibited, nor
increased (data not shown). The same result was obtained
using confluent cells, i.e. non-dividing cells (data not
shown). Thus the plasmid DNA was still biologically
active but transfection efficiency was not enhanced by
covalently coupled IBB peptides. At high IBB peptide /
plasmid ratios, the inhibition of transfection was a conse-
quence of the photoactivation as non-photoactivated IBB
/ plasmid complexes of the same high ratio exhibited the
same transfection activity as the control plasmid (Figure
1). In an effort to determine why covalent coupling of IBBBMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/14
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peptide to DNA did not give the effect we had expected,
we examined the binding characteristics of IBB peptide.
Interaction of free and covalently coupled IBB peptide 
with importin β – Nuclear import assay
Interaction of the free IBB peptide with its intracellular tar-
get, namely importin β, was studied using recombinant
importin β-GST fixed on glutathione-sepharose beads. In
a first series of assays, we tested the interaction of either
free IBB peptide or, as a control that of cytochrome c, with
importin  β (Figures 2A and 2B). The IBB peptide was
detected in the bound fraction (Figure 2B), whereas cyto-
chrome c was almost completely recovered in the
unbound fraction (Figure 2A). This suggested that the syn-
thetic IBB peptide was still able to interact with its nuclear
import receptor, namely importin β, as the hSRP1α IBB
domain described by Weis et al. [21].
However, this interaction was shown to be non-specific in
a series of control experiments as the IBB peptide also
interacted with importin α and GST (Figures 2C and 2D).
No interaction could be detected between the non-func-
tionalized glutathione-sepharose beads and the IBB pep-
tide (data not shown). Thus, the IBB peptide was shown
to be able to interact with cytoplasmic receptors that
mediate karyopheric proteins nuclear import, but not
specifically.
Transfection of HeLa cells using a ternary lipoplexe IBB peptide / plasmid / RPR120535 cationic lipid Figure 1
Transfection of HeLa cells using a ternary lipoplexe IBB peptide / plasmid / RPR120535 cationic lipid. Lipoplexes 
were prepared in bicarbonate buffer (150 mM NaCl, 20 mM NaHCO3, pH 10) and diluted with serum-containing cell culture 
medium. The peptide was covalently coupled (covalent) or electrostatically associated (electrostatic) to pXL3031 luciferase-
encoding plasmid at a ratio varying from 0 to 500 IBB peptide / plasmid (mol / mol). Luciferase expression was evaluated 24 h 
after transfection.
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We then coupled IBB peptide to plasmid DNA. We first
verified the formation of the IBB-TFPAM conjugate by
HPLC (Figure 3A) followed by SDS-PAGE analysis of the
eluted compounds (Figure 3B). At pH 2, the reaction can-
not occur, peaks corresponding to non-coupled IBB (I)
and TFPAM (T1, T2, T3) were observed. R1 and R2 peaks
that appeared only when the reaction was performed at
pH 7.5 have migration properties on SDS-PAGE consist-
ent with a 7.5 kDa-peptide. Considering their respective
retention times, R1 was probably non-reacting IBB and R2
the TFPAM-IBB conjugate. We then added IBB-TFPAM to
plasmid DNA and photoactivated the mixture. We were
Qualitative analysis of IBB peptide binding on importin α, β, and GST Figure 2
Qualitative analysis of IBB peptide binding on importin α, β, and GST. Binding assays were performed between 
importin β-GST (Imp β) and IBB peptide (IBB) or cytochrome c (Cytc) (A and B) and between importin α-GST (Imp α), impor-
tin β-GST (Impβ), or GST and IBB peptide (C and D). Importin-GST or GST were fixed on glutathione-sepharose beads and 
1.25 µg (1), 2.5 µg (2) or 5 µg (3) of IBB peptide, or 1.25 µg (4), 2.5 µg (5) or 5 µg (6) of cytochrome c were applied to these 
beads. The unbound (A and C) and bound (B and D) fractions were analyzed on 10 % NuPAGE gels (Invitrogen) followed by 
Coomassie Blue staining (A and B) or silver nitrate staining (C and D). M: protein size ladder (Novex), C1: 500 ng IBB peptide 
and 500 ng cytochrome c as a control, C2: 500 ng GST, 500 ng importin α and 500 ng importin β as a control.
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Monitoring of IBB coupling to TFPAM-6 and of IBB-TFPAM coupling to plasmid DNA. Interaction of IBB with importin β after  covalent coupling with plasmid Figure 3
Monitoring of IBB coupling to TFPAM-6 and of IBB-TFPAM coupling to plasmid DNA. Interaction of IBB with 
importin β after covalent coupling with plasmid. The coupling reaction of IBB peptide to TFPAM-6 was monitored by 
reverse phase chromatography using a C18 column, the compounds were detected by UV absorbance at 220 nm (A). HPLC 
profiles of starting material (IBB, TFPAM-6) and conjugates obtained after 1 h reaction either at pH 7.5 (R pH 7.5) or at pH 2 
(R pH2) at room temperature are shown. The elution peaks of 'R pH 7.5' reaction (R1, R2, R3), 'IBB' (IBB), 'R pH 2' (T1, T2, I, 
T3) chromatograms were collected and analyzed on 10 % NuPAGE electrophoresis gels followed by silver nitrate staining (B). 
L : 12 marker (Novex). Binding assays were performed between importin β-GST and IBB / plasmid complexes where IBB pep-
tide was either covalently coupled (covalent) or electrostatically associated (electrostatic) to pXL3031 plasmid (C). The IBB / 
plasmid ratio was either 10 or 25 (mol / mol). The unbound (1) and bound (2) fractions were analyzed, pXL3031 was used as a 
control (C). Binding assay was also performed between pXL3031 plasmid or pXL3031-IBB covalently coupled chimera (50 mol 
IBB / mol plasmid) and importin β-sepharose beads (D). The unbound (chimera: 1c and pXL3031: 1p), bound (chimera: 2c and 
pXL3031: 2p) fractions, control pXL3031 (Cp) and control chimera (Cc) were analyzed. For these assays (C and D) the analy-
sis were performed on 0.8 % agarose gel stained with ethidium bromide. M: 1 kb DNA ladder (Gibco BRL). C: 500 ng pXL3031 
plasmid as a control.
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unable to purify the conjugate IBB-TFPAM-plasmid DNA
from free IBB-TFPAM because IBB peptide bound to every
support, dialysis membrane, plastic tube, etc. Every exper-
iment was performed in low binding tubes to prevent
non-specific interaction of the IBB peptide with the wall
of the tubes. We have then no direct proof of the forma-
tion of the conjugate IBB-TFPAM-DNA except the fact that
photoactivation of the complex IBB plasmid led to an
inhibition of transfection. We have previously shown that
the covalent coupling of ligands to plasmid DNA could
cause inhibition of transfection, probably by transcrip-
tional inactivation [26].
We next examined whether IBB peptide was still able to
interact with its receptor when it was coupled to DNA. IBB
peptide was coupled to DNA at two ratios and applied to
importin β-containing beads. Bound and unbound frac-
tions were analyzed by electrophoresis on agarose gel. As
appeared in Figure 3C, at the ratio of 25 IBB peptides /
plasmid (mol / mol), the covalent chimera were retained
on importin β beads. However, this retention was also
observed with non-covalently associated IBB / plasmid
(Figure 3C). We therefore verified that plasmid DNA
alone (without IBB added) was unable to bind to these
beads (Figure 3D). Taken together, these results proved
that IBB was able to lead to the retention of the plasmid
on importin β-conjugated beads even when non-covalent
interactions occurred between the peptide and DNA. We
hypothesized that covalent interactions occurred when
photoactivation was applied, but we could not prove their
existence due to the formation of strong non-covalent
interactions between IBB and plasmid DNA.
Since IBB peptide associated with plasmid DNA was still
able to bind importin β, we next evaluated whether IBB
peptide was able to improve the nuclear import of plas-
mid DNA. We used the digitonin-permeabilized cells
model with fluorescent plasmid. The IBB peptide was cou-
pled to fluorescent plasmid at the molar ratio of 25 and
incubated with digitonin-permeabilized HeLa cells. As
shown in Figure 4, fluorescence was concentrated on the
remaining cytoplasm and the nuclear envelope (Figure
4B), the staining pattern was the same with fluorescent
plasmid alone, without IBB peptide covalent coupling
(Figure 4A). No fluorescence was observed within cell
nuclei.
It seemed that IBB peptide was still able to interact with its
specific receptor, but despite this interaction no signifi-
cant improvement of nuclear import of plasmid could be
obtained.
Since IBB peptide was also able to interact non-specifically
with other proteins, IBB-plasmid complexes might be
sequestered by unspecific interactions with cytoplasmic
proteins. Nevertheless, in an effort to obtain an improve-
ment of gene transfer, we studied other formulations of
DNA and IBB peptide and observed that IBB peptide /
plasmid complexes formed by self assembly, without
photoactivation, were able to increase gene transfer activ-
ity in particular conditions of transfection.
Gene transfer efficiency of self assembling complexes 
composed of IBB peptide / plasmid DNA / RPR120535 
cationic lipid
We evaluated the effect of IBB peptide adjunction on
transfection efficiency of DNA / cationic lipid complexes.
These lipoplexes were prepared by mixing the lipofectant
RPR120535 with plasmid DNA and IBB peptide in 150
mM NaCl in water and then diluted in serum containing
cell culture medium. Without IBB, this formulation is
known to lead to small lipoplexes and inefficient transfec-
tion [22–24].
The presence of IBB peptide greatly increased reporter
gene expression. At ratios of 250 and 500 IBB peptide /
plasmid DNA (mol / mol), i. e. 0.8 to 1.6 IBB peptide /
plasmid DNA (w / w), we observed a 20-fold increase of
Fluorescence microscopy of nuclear import assay of IBB pep- tide-fluorescent plasmid in the digitonin-permeabilized HeLa  cells system Figure 4
Fluorescence microscopy of nuclear import assay of 
IBB peptide-fluorescent plasmid in the digitonin-per-
meabilized HeLa cells system. Digitonin treated HeLa 
cells were incubated with 5 µg fluorescent plasmid alone (A) 
or covalently coupled to IBB peptide at the ratio of 25 IBB 
peptide / plasmid (mol / mol) (B), or with 1 µg fluorescent 
BSA-NLS (C) as a positive nuclear import control. The assay 
was performed for 30 min at 30°C in the presence of an 
energy regenerating system and 50 % (vol / vol) HeLa cyto-
plasmic extracts. Cells were observed with a 100 × objective 
lens.
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luciferase gene expression (Figure 5). Enhancement of
gene transfer efficiency depended on IBB peptide / plas-
mid DNA molar ratio: reporter gene expression increased
with the amount of added IBB peptide. Transfection
assays were also performed with lipoplexes prepared in
water. In those assays, gene expression was increased 100-
fold by adding 500 moles IBB peptide per mole plasmid
DNA (data not shown).
We then wondered if this transfection enhancement could
be attributed to a nuclear targeting of plasmid DNA by IBB
peptide or to a change in the overall physico-chemical
properties of plasmid DNA / RPR120535 lipoplexes.
Physico-chemical properties of the plasmid DNA / IBB 
complexes
The IBB peptide is globally basic, characterised by the
presence of 17 R and K aminoacids, protonated at physio-
logical pH, and of 10 acidic residues (D, E). Its charge at
neutral pH is globally positive, for this reason it can
potentially form complexes with negatively charged DNA
molecules.
The formation of self-assembling IBB peptide / plasmid
DNA complexes was examined by analysis of their electro-
phoretic mobility on agarose gel (Figure 6). At ratios of
100 and 250 IBB / plasmid (mol / mol), i. e. 0.3 and 0.8
IBB / plasmid (w / w), the migration of plasmid DNA was
delayed. For ratios of 500 to 2000 IBB / plasmid (mol /
mol), i.e. 1.6 to 6 IBB / plasmid (w / w), no DNA migra-
tion occurred. This lack of migration indicates
neutralization of nucleic acids by cationic IBB peptide and
/ or formation of large complexes that cannot migrate
through the gel.
Lipoplexes size determination
The size of the ternary complexes was monitored using
dynamic light scattering and the size distribution of the
complex's populations was determined by size distribu-
tion processor analysis. When compared to binary DNA /
cationic lipid complexes prepared in water, the addition
of 250 mol of IBB peptide per mol plasmid DNA induced
a marked size increase, leading to 3000 nm sized com-
plexes (Figure 7A). In the case of 500 IBB / plasmid DNA
(mol / mol), the lipoplexes were totally aggregated, as eye-
observable aggregates could be seen (data not shown). In
this case, lipoplex size cannot be precisely defined due to
the detection limits of the nanosizer.
Lipoplexes prepared in water or in 150 mM NaCl and then
diluted in serum-containing cell culture medium are
known to be small and to lead to inefficient transfection
[22–24]. On the contrary, preparing lipoplexes in bicarbo-
nate buffer (20 mM NaHCO3, 150 mM NaCl, pH 10), and
diluting them in serum-containing cell culture medium
leads to bigger lipoplexes and highly efficient transfection.
The size of ternary IBB / DNA / RPR120535 complexes
Transfection of HeLa cells using a ternary lipoplex Figure 5
Transfection of HeLa cells using a ternary lipoplex. 
IBB peptide / plasmid / RPR120535 cationic lipid lipoplexes 
were prepared in 150 mM NaCl and diluted with serum-con-
taining cell culture medium. The peptide was electrostatically 
associated to pXL3031 luciferase-encoding plasmid at a ratio 
varying from 0 to 500 IBB peptide / plasmid (mol / mol). Luci-
ferase expression was evaluated 24 h after transfection.
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prepared in bicarbonate buffer (20 mM NaHCO3, 150
mM NaCl, pH 10) were around 2000–3000 nm (Figure
7B), which was comparable to the size of IBB / plasmid
DNA / RPR120535 lipoplexes prepared in water with 250
and 500 IBB / plasmid (mol / mol) (Figure 7A). Transfec-
tion with these ternary lipoplexes prepared in bicarbonate
buffer was as efficient as transfection with binary plasmid
DNA / RPR120535 complexes prepared in bicarbonate
buffer (data not shown).
IBB peptide / plasmid / lipofectant complexes that exhib-
ited an improvement of transfection clearly had different
physico-chemical characteristics.
Discussion
In an aim to increase the nuclear targeting of plasmid
DNA, we have covalently coupled importin α nuclear
localization sequence, the IBB domain, to plasmids.
Covalent coupling of 50 to 500 IBB peptides per plasmid
(mol / mol) led to a decrease in reporter gene expression.
This inhibition of transfection was a consequence of the
photoactivation since non-photoactivated IBB peptide /
plasmid complexes of the same high ratio exhibited the
same transfection activity as the control plasmid. This pro-
vides an indirect proof of the formation of covalent
interactions between IBB-TFPAM and plasmid DNA. For
lower peptide / plasmid molar ratio, we could not detect
any increase in lipofectant-mediated transfection.
We used in vitro tests to evaluate IBB peptide interactions
with the nuclear import machinery. The IBB peptide
interacted with importin β, although non-specifically,
since it also interacted with importin α and GST. In the
cytoplasm, the IBB domain of importin α is never accessi-
ble: it is either associated with the NLS binding site of the
same importin α [7,8], or with importin β. These two con-
formations should avoid this basic IBB from interacting
with non-relevant cytoplasmic proteins. This could
explain the interaction observed between IBB peptide and
importin α. However, IBB interacted with GST protein;
this interaction was not physiologically relevant and likely
resulted from non-specific electrostatic association. In
agreement with these results, the nuclear import either in
the digitonin-permeabilized cell system or in transfection
assays with fluorescent plasmid DNA was not increased
when plasmid DNA was coupled with IBB peptide (data
not shown): IBB peptide should interact with non-rele-
vant cytoplasmic proteins before gaining access to the
nuclear import machinery. However, fluorescence micro-
scopy is not a highly sensitive method and plasmid DNA
could also have entered the nuclei without being detecta-
ble. Another hypothesis is that IBB peptide was not
functional.
Our strategy of using IBB sequence to enhance nuclear
import of plasmid DNA was not demonstrated probably
due to the propensity of IBB to interact non-specifically
with irrelevant proteins. However, we hypothesized that
this highly cationic peptide could associate with
polyanionic plasmid DNA. We demonstrated that this
association exists, as illustrated by the decrease or
complete loss of plasmid agarose gel electrophoresis
migration, depending on the IBB / plasmid ratio. Another
indication of this self-association is the increase in lipo-
plex size when IBB peptide is used as an additive in the
formulation.
Size distribution of IBB peptide / plasmid / RPR120535 ter- nary lipoplexes Figure 7
Size distribution of IBB peptide / plasmid / 
RPR120535 ternary lipoplexes. Lipoplexes were pre-
pared at 0, 10, 100 and 250 IBB peptide / plasmid (mol / mol) 
by mixing plasmid with IBB peptide and then adding 
RPR120535 cationic lipid and diluting the preparation to the 
tenth either in water (A) or in NaCl 150 mM, 20 mM 
NaHCO3, pH 10 (B). After 5 min equilibration at room tem-
perature, lipoplex size was evaluated by the measure of 
dynamic light scattering at the angle of 90° for 10 min.
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We observed a 20-fold increase in gene expression when
plasmid DNA was self-associated to IBB peptide prior to
compaction with a cationic lipid such as RPR120535, as
compared to transfection by binary plasmid / cationic
lipid lipoplexes. This result was obtained in conditions
known to lead to inefficient transfection, i.e. lipoplexes
prepared in 150 mM NaCl and diluted in serum-contain-
ing cell culture medium. Serum is known to strongly
inhibit gene transfer in vitro, through the formation of
small sized DNA / cationic lipid complexes [22,23]. The
IBB peptide seems to be responsible for the formation of
large aggregates, which promote an efficient transfection.
The same transfection enhancement has already been
described when plasmid DNA is pre-compacted by
cationic peptides derived from histone and protamine
before complexing with a lipofectant [24]. As for the IBB
peptide, the histone or protamine derived peptide pro-
mote the intracellular accumulation of fluorescent plas-
mid DNA in large cytoplasmic vesicles (data not shown)
[24]. This previous data, in conjunction with the present
results with IBB peptide, point to a general mechanism of
action of cationic peptides-containing lipoplexes. Such
ternary formulation displays high serum-resistant trans-
fecting activity through the intracellular build-up of large
aggregated complexes, which might have favored endo-
some-disrupting capacity.
Methods
Plasmid, proteins and peptide
Plasmid pXL3031 contains the enhancer-promoter from
the immediate-early gene of cytomegalovirus (CMV), the
engineered cytoplasmic luciferase gene (luc+) and the
SV40 polyadenylation site. Luc+ is a high activity cytosolic
form of luciferase obtained from pGL3 vectors (Promega).
This pCOR plasmid (bearing a conditional origin of repli-
cation) was grown and purified as described [25]. Fluores-
cent plasmids were prepared as described previously [26]:
a p-azido-tetrafluoro-benzyl-lissamine conjugate was syn-
thesized and used to covalently associate fluorescent mol-
ecules to plasmid DNA by photoactivation (100 to 200
fluorophores per plasmid DNA).
The IBB peptide is composed of hSRP1α 11–54 amino-
acids (human importin α 2, [20]), fused to a histidine tag
(HHHHHH) and a myc-tag (EQKLISEEDL). Peptide
[H]HHHHHHGEQKLISEEDLAARLHRFKNKGKD-
STEMRRRRIEVNVELRKAKKDDQMLKRRNVSC [OH] was
chemically synthesized and purified by reverse-phase
chromatography (Dictagene S.A., Suisse). Lyophilized
aliquots were maintained at -20°C, or dissolved in 50 mM
HEPES buffer pH 7.5 (1 µg/µl) containing 1 µg/ml apro-
tinin, leupeptin and pepstatin and maintained at -80°C.
Recombinant importin α-GST and importin β-GST were
prepared as described previously [15].
Covalent coupling of IBB peptide to plasmid DNA
IBB peptide was covalently coupled to plasmid DNA using
a previously described protocol [15]. Briefly, IBB peptide
was incubated for 1 h at room temperature in 50 mM
HEPES buffer pH 7.5 with the linker N-(4-azido-2,3,5,6
tetrafluorobenzyl)-6-maleimidyl hexanamide (TFPAM-
6). The maleimide moiety of TFPAM-6 reacted with the
thiol of the terminal cysteine of IBB peptide to form IBB-
TFPAM. This reaction occurs only in a narrow range of pH,
around pH 7, but at pH 2 the reaction does not occur.
Reactions at pH 7.5 and at pH 2 were monitored by
reverse-phase chromatography using a C18 Vydac – 238
TP 54 column (250 × 4.6 mm), and an elution gradient of
acetonitrile / water 0.1 % TFA (from 10 to 60 % ace-
tonitrile in 30 min) with a flow rate of 1 ml / min. Eluted
compounds were detected by UV absorbance at 220 nm.
IBB-TFPAM was dialyzed 2 h at room temperature against
50 mM HEPES pH 7.5, using a Spectra / Por asymmetric
cellulose ester dialysis membrane (MWCO 2,000 Da).
Plasmid DNA and IBB-TFPAM were mixed, placed in a 96-
well plate on an ice bath and subjected to photoactivation
15 min at 365 nm, under a sun lamp (Rad free UV lamp-
365 nm, Schleicher and Schuell, Ecquevilly, France). Plas-
mid DNA concentration was evaluated using the interca-
lating agent Picogreen (Molecular Probes) and peptide
concentration was determined using Pierce BCA assay
(Interchim).
Importin binding assay
Recombinant importin α-GST and importin β-GST were
coupled to glutathione-sepharose 4B beads (Amersham
Pharmacia Biotech) by incubation 30 min at room tem-
perature of 1 µg protein per 10 µl of beads (10 µg/ml final
protein concentration in binding buffer: 20 mM HEPES
pH 7, 150 mM potassium acetate, 2 mM magnesium
acetate, 2 mM DTT and 0.1 % casaminoacids). The beads
were collected by centrifugation and washed five times
with binding buffer. Such a resin is called a functionalized
resin.
For IBB peptide and cytochrome c binding assays: IBB
peptide or cytochrome c were applied to importin α – and
importin β-functionalized beads. For IBB / plasmid com-
plexes binding assay: plasmid either covalently coupled or
electrostatically associated to IBB peptide was applied to
importin  β-functionalized beads. For plasmid binding
assay: plasmid was applied to importin β-functionalized
beads.
After 1 h incubation at room temperature with soft agita-
tion, the beads were collected by centrifugation and the
supernatant removed (this supernatant is designated the
"unbound fraction"). The beads were then washed five
times with binding buffer. Proteins or complexes coupled
to one volume of beads were eluted by heating 15 min atBMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/14
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80°C in one volume of elution buffer (0.1 % SDS, 0.1 M
EDTA pH 8). The beads were collected by centrifugation
and the supernatant was removed (this supernatant is
called the "bound fraction"). The unbound and bound
fractions were analyzed by gel electrophoresis. For IBB
peptide and cytochrome c binding assay analysis, 10 %
NuPAGE pre-cast gels (Invitrogen) were used, and then
stained either by Coomassie Blue or silver nitrate staining
[27]. For plasmid and IBB / plasmid binding assay analy-
sis 0.8 % agarose gel in TBE buffer was used, and then
stained with ethidium bromide.
Transfection studies
HeLa cells (ATCC CCL-2) were grown in complete cell cul-
ture medium, composed of Minimal Essential Medium
(or MEM, GIBCO BRL) supplemented with 2 mM
glutamine, 100 units / ml penicillin, 100 µg/ml strepto-
mycin and 10 % foetal bovine serum. Cells were grown at
37°C in a 5 % CO2 / air incubator.
For plasmid DNA expression studies, 24-well culture
plates were seeded with 60,000 cells per well one day
before transfection. Lipopolyamine RPR120535 [28] was
used as a gene vector. Plasmids were diluted in 150 mM
NaCl / water pH 6 or 150 mM NaCl / 20 mM NaHCO3 /
water pH 10 and mixed (vol / vol) with RPR120535 at the
final concentration of 2.5 µg/ml plasmid DNA and 6
nmol RPR120535 /µg DNA. The complexes were allowed
to form 15 min at room temperature and then diluted to
the tenth in complete cell culture medium containing 10
% serum before addition to the cells (1 ml per well).
After 24 h at 37°C in a 5 % CO2 / air incubator, the cells
were washed twice with PBS and harvested with 200 µl of
cell culture lysis reagent (Promega). Luciferase expression
was quantified on 10 µl of centrifugated lysate superna-
tant using a luciferase assay kit (Promega). Light emission
was measured in white 96-microwell plates (OptiPlate TM
96, Packard) using a Wallac Victor2 microplate reader.
Light emission, expressed in CPS (count per second), was
normalized to the protein concentration of each sample,
determined using Pierce BCA assay (Interchim).
Nuclear transport assay on digitonin permeabilized cells
Digitonin-permeabilized HeLa cells were prepared
according to Adam et al. [29,30]. Cells grown to 90 %
confluency on glass coverslips were immersed for 5 min
on ice in 40 µg/ml ice-cold digitonin (Sigma) diluted in
nuclear import buffer (20 mM HEPES pH 7.3, 110 mM
potassium acetate, 5 mM sodium acetate, 2 mM magne-
sium acetate, 0.5 mM EGTA, 2 mM DTT, 1 µg/ml apro-
tinin, leupeptin and pepstatin) and then washed twice in
cold nuclear import buffer. We then deposited a 50 µl
drop of nuclear import buffer containing an ATP regener-
ating system (1 mM ATP, 0.5 mM GTP, 10 mM creatine
phosphate and 0.4 U / ml creatine phosphokinase), HeLa
cytoplasmic extracts (~7 mg/ml final protein concentra-
tion), and 5 µg plasmid DNA labelled with lissamine
(26), alone or complexed with IBB peptide (1 mol plas-
mid per 25 or 50 mol IBB). Nuclear transport was allowed
to proceed for 30 min at 30°C. Coverslips were then
rinsed twice with cold transport buffer, fixed in 2 % para-
formaldehyde containing 0.1 % glutaraldehyde, and
mounted on slides in PBS containing 50 % glycerol. Slides
were fixed with nail polish and examined with a Zeiss Axi-
ophot fluorescence microscope as described previously.
Particle size measurements
Plasmid DNA / IBB peptide complexes were prepared at
molar ratios of 10, 25, 50, 100, 250, 500 (IBB peptide /
plasmid DNA) in a final volume of 40 µl water. These
complexes were then mixed (vol / vol) with RPR120535
at the molar ratio of 6 nmol RPR120535/µg plasmid
DNA. Complexes were allowed to form 15 min at room
temperature and then diluted to the tenth in complete cell
culture medium (final volume: 800 µl). Size analyses were
performed on a Coulter N4-Plus nanosizer. After 3 min
equilibration, sizes were evaluated by the measure of
dynamic light scattering at an angle of 90° for 10 min.
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